{
    "name": "sacituzumab govitecan",
    "comment": "Rx",
    "other_names": [
        "Trodelvy",
        "sacituzumab govitecan-hziy"
    ],
    "classes": [
        "Antineoplastics",
        "Topoisomerase Inhibitors"
    ],
    "source": "https://reference.medscape.com/drug/trodelvy-sacituzumab-govitecan-1000280",
    "pregnancy": {
        "common": [
            "Based on its mechanism of action, teratogenicity and/or embryofetal lethality may occur when administered to a pregnant female",
            "No data available in pregnant women to inform the drug-associated risk",
            "Sacituzumab contains a genotoxic component, SN-38, and is toxic to rapidly dividing cells",
            "Advise pregnant females and those of reproductive potential of the potential risk to a fetus",
            "Verify pregnancy status of females of reproductive potential prior to initiation"
        ],
        "specific": [
            {
                "type": "Contraception",
                "description": [
                    "Females of reproductive potential: Use effective contraception during treatment and for 6 months after final dose",
                    "Males of female partners of reproductive potential: Use effective contraception during treatment and for 3 months final dose"
                ]
            },
            {
                "type": "Infertility",
                "description": [
                    "Based on findings in animals, fertility may be impaired in females of reproductive potential"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "No information available on the presence of sacituzumab govitecan-hziy or SN-38 in human milk, effects on breastfed children, or effects on milk production",
            "Advise females not to breastfeed during treatment and for 1 month after final dose"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": [
                {
                    "type": "Neutropenia",
                    "description": [
                        "Severe neutropenia may occur; withhold for ANC<1,500/mm",
                        "3 ",
                        "or neutropenic fever",
                        "Monitor blood cell counts periodically during treatment",
                        "Consider G-CSF for secondary prophylaxis",
                        "Initiate anti-infective treatment in patient with febrile neutropenia without delay"
                    ]
                },
                {
                    "type": "Diarrhea",
                    "description": [
                        "Severe diarrhea may occur",
                        "Monitor patients with diarrhea and give fluid and electrolytes as needed",
                        "Administer atropine, if not contraindicated, for early diarrhea of any severity",
                        "At onset of diarrhea, evaluate for infectious causes; if negative, promptly initiate loperamide",
                        "If severe diarrhea occurs, withhold therapy until resolved to Grade â‰¤1 and reduce subsequent doses"
                    ]
                }
            ]
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to sacituzumab"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Therapy is emetogenic; premedicate for prevention of chemotherapy-induced nausea and vomiting (CINV)",
                "Individuals who are homozygous for the uridine diphosphate-glucuronosyl transferase 1A1 (UGT1A1)*28 allele are at increased risk for neutropenia and may be at increased risk for other adverse reactions following initiation of treatment; closely monitor for severe neutropenia; appropriate dose in these patients is unknown and should be based on individual patient tolerance to treatment",
                "Closely monitor patients with known reduced UGT1A1 activity for adverse reactions; withhold or permanently discontinue drug based on severity of observed adverse reactions in patients with evidence of acute early-onset or unusually severe adverse reactions, which may indicate UGT1A1 reduced function",
                "Teratogenicity and/or embryofetal lethality may occur when administered to pregnant females"
            ],
            "specific": [
                {
                    "type": "Hypersensitivity",
                    "description": [
                        "Severe and life-threatening hypersensitivity reactions occur",
                        "Anaphylactic reactions have been observed in clinical trials ",
                        "Premedicate and monitor for signs and symptoms of infusion-related reactions during and for 30 min after each infusion"
                    ]
                },
                {
                    "type": "Neutropenia",
                    "description": [
                        "May cause severe or life-threatening neutropenia",
                        "Withhold for ANC <1,500/mm",
                        "3",
                        " on Day 1 or ANC <1,000/mm",
                        "3",
                        " on Day 8 of any cycle, or neutropenic fever",
                        "Febrile neutropenia also occurred, including patients with mTNBC after <2 prior therapies"
                    ]
                },
                {
                    "type": "Diarrhea",
                    "description": [
                        "Severe diarrhea may occur",
                        "At the onset of diarrhea, evaluate for infectious causes, and, if negative, promptly initiate loperamide 4 mg initially followed by 2 mg per episode of diarrhea (not to exceed 16 mg/day)",
                        "Discontinue loperamide 12 hr after diarrhea resolves; consider additional supportive measures (eg, fluid and electrolyte substitution) as clinically indicated",
                        "Patients who exhibit an excessive cholinergic response to treatment (eg, abdominal cramping, diarrhea, salivation) can receive appropriate premedication (eg, atropine) for subsequent treatments"
                    ]
                },
                {
                    "type": "Drug interaction overview",
                    "description": [
                        "UGT1A1 substrate  ",
                        "UGT1A1 inhibitors",
                        "Avoid coadministration",
                        "UGT1A1 inhibitors may increase the incidence of adverse reactions due to potential increase in systemic exposure to SN-38 ",
                        "UGT1A1 inducers",
                        "Avoid coadministration",
                        "UGT1A1 enzyme inducers may substantially reduce exposure to SN-38 "
                    ]
                }
            ]
        }
    },
    "interactions": [
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "siponimod",
            "description": {
                "common": "siponimod and sacituzumab govitecan both increase  immunosuppressive effects; risk of infection. Use Caution/Monitor. Caution if coadministered because of additive immunosuppressive effects during such therapy and in the weeks following administration. When switching from drugs with prolonged immune effects, consider the half-life and mode of action of these drugs to avoid unintended additive immunosuppressive effects."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Decreased hemoglobin",
            "percent": "93"
        },
        {
            "name": "Decreased leukocytes",
            "percent": "91"
        },
        {
            "name": "Decreased neutrophils",
            "percent": "82"
        },
        {
            "name": "Increased activated partial thromboplastin time",
            "percent": "60"
        },
        {
            "name": "Neutropenia",
            "percent": "64"
        },
        {
            "name": "Nausea",
            "percent": "69"
        },
        {
            "name": "Diarrhea",
            "percent": "63"
        },
        {
            "name": "Fatigue",
            "percent": "57"
        },
        {
            "name": "Increased alkaline phosphatase",
            "percent": "57"
        },
        {
            "name": "Anemia",
            "percent": "52"
        },
        {
            "name": "Decreased magnesium",
            "percent": "51"
        },
        {
            "name": "Decreased calcium",
            "percent": "49"
        },
        {
            "name": "Vomiting",
            "percent": "49"
        },
        {
            "name": "Increased glucose",
            "percent": "48"
        },
        {
            "name": "Increased AST",
            "percent": "45"
        },
        {
            "name": "Decreased albumin",
            "percent": "39"
        },
        {
            "name": "Alopecia",
            "percent": "38"
        },
        {
            "name": "Increased ALT",
            "percent": "35"
        },
        {
            "name": "Constipation",
            "percent": "34"
        },
        {
            "name": "Rash",
            "percent": "31"
        },
        {
            "name": "Decreased platelets",
            "percent": "30"
        },
        {
            "name": "Decreased appetite",
            "percent": "30"
        },
        {
            "name": "Decreased potassium",
            "percent": "30"
        },
        {
            "name": "Decreased phosphate",
            "percent": "29"
        },
        {
            "name": "Abdominal pain",
            "percent": "26"
        },
        {
            "name": "Respiratory tract infection",
            "percent": "26"
        },
        {
            "name": "Decreased sodium",
            "percent": "25"
        },
        {
            "name": "Increased magnesium",
            "percent": "24"
        },
        {
            "name": "Hyperglycemia",
            "percent": "24"
        },
        {
            "name": "Neuropathy",
            "percent": "24"
        },
        {
            "name": "Headache",
            "percent": "23"
        },
        {
            "name": "Back pain",
            "percent": "23"
        },
        {
            "name": "Dizziness",
            "percent": "22"
        },
        {
            "name": "Cough",
            "percent": "22"
        },
        {
            "name": "Dyspnea",
            "percent": "21"
        },
        {
            "name": "Hypomagnesemia",
            "percent": "21"
        },
        {
            "name": "Urinary tract infection",
            "percent": "21"
        },
        {
            "name": "Decreased glucose",
            "percent": "19"
        },
        {
            "name": "Hypokalemia",
            "percent": "19"
        },
        {
            "name": "Edema",
            "percent": "19"
        },
        {
            "name": "Pruritus",
            "percent": "17"
        },
        {
            "name": "Arthralgia",
            "percent": "17"
        },
        {
            "name": "Hypophosphatemia",
            "percent": "16"
        },
        {
            "name": "Dry skin",
            "percent": "15"
        },
        {
            "name": "Pyrexia",
            "percent": "14"
        },
        {
            "name": "Mucositis",
            "percent": "14"
        },
        {
            "name": "Thrombocytopenia",
            "percent": "14"
        },
        {
            "name": "Insomnia",
            "percent": "13"
        },
        {
            "name": "Dehydration",
            "percent": "13"
        },
        {
            "name": "Dysgeusia",
            "percent": "11"
        },
        {
            "name": "Pain in extremity",
            "percent": "11"
        },
        {
            "name": "Neutropenia",
            "percent": "43"
        },
        {
            "name": "Decreased neutrophils",
            "percent": "32"
        },
        {
            "name": "Decreased leukocytes",
            "percent": "26"
        },
        {
            "name": "Anemia",
            "percent": "12"
        },
        {
            "name": "Increased activated partial thromboplastin time",
            "percent": "12"
        },
        {
            "name": "Diarrhea",
            "percent": "9"
        },
        {
            "name": "Hypophosphatemia",
            "percent": "9"
        },
        {
            "name": "Fatigue",
            "percent": "8"
        },
        {
            "name": "Nausea",
            "percent": "6"
        },
        {
            "name": "Vomiting",
            "percent": "6"
        },
        {
            "name": "Decreased hemoglobin",
            "percent": "6"
        },
        {
            "name": "Decreased phosphate",
            "percent": "5"
        },
        {
            "name": "Dehydration",
            "percent": "5"
        },
        {
            "name": "Decreased sodium",
            "percent": "4.7"
        },
        {
            "name": "Hyperglycemia",
            "percent": "4"
        },
        {
            "name": "Increased magnesium",
            "percent": "4"
        },
        {
            "name": "Thrombocytopenia",
            "percent": "3"
        },
        {
            "name": "Rash",
            "percent": "3"
        },
        {
            "name": "Urinary tract infection",
            "percent": "3"
        },
        {
            "name": "Respiratory tract infection",
            "percent": "3"
        },
        {
            "name": "Dyspnea",
            "percent": "3"
        },
        {
            "name": "Decreased platelets",
            "percent": "3"
        },
        {
            "name": "Decreased magnesium",
            "percent": "3"
        },
        {
            "name": "Decreased calcium",
            "percent": "3"
        },
        {
            "name": "Increased glucose",
            "percent": "3"
        },
        {
            "name": "Increased AST",
            "percent": "3"
        },
        {
            "name": "Decreased potassium",
            "percent": "3"
        },
        {
            "name": "Hypokalemia",
            "percent": "2"
        },
        {
            "name": "Increased alkaline phosphatase",
            "percent": "2"
        },
        {
            "name": "Increased ALT",
            "percent": "2"
        },
        {
            "name": "Decreased glucose",
            "percent": "2"
        },
        {
            "name": "Decreased albumin",
            "percent": "1"
        },
        {
            "name": "Headache",
            "percent": "1"
        },
        {
            "name": "Constipation",
            "percent": "1"
        },
        {
            "name": "Abdominal pain",
            "percent": "1"
        },
        {
            "name": "Mucositis",
            "percent": "1"
        },
        {
            "name": "Decreased appetite",
            "percent": "1"
        },
        {
            "name": "Hypomagnesemia",
            "percent": "1"
        }
    ]
}